ADVANCED OPTIONS FOR MANAGING YOUR DIABETIC NEUROPATHY

Not finding relief from diabetic neuropathy? Talk to us about advanced care.

Painful Diabetic Neuropathy (PDN): A Chronic, Debilitating Pain with Limited Treatment Options
Diabetic peripheral neuropathy is a form of nerve damage caused by high blood sugar that affects nearly half of all adults with diabetes. For millions of people, this condition leads to chronic pain, numbness, and disrupted sleep, while significantly increasing the risk of serious complications like falls, infections, and ulcers.

Current Treatments Leave Room for Improvement
Unfortunately, traditional management strategies—including physical therapy, injections, and standard medications—frequently fail to provide long-term relief, and options like opioids carry risks of dependency without truly improving daily functionality or quality of life.

Advanced Treatment Options for Diabetic Neuropathy

HFX™

High-Frequency Nerve Pain Relief

Nevro HFX is an FDA-approved spinal cord stimulation therapy using high-frequency pulses to calm nerve pain without a tingling sensation. It reduces shooting, burning, and “pins and needles” discomfort, improves sleep, and can even help restore physical feeling in the feet.

Proclaim™ DRG Therapy

Targeted Relief for Foot & Leg Pain

Proclaim™ DRG Therapy precisely targets the dorsal root ganglion—the nerve cluster managing lower extremity pain. By intercepting pain signals right at the source, this recharge-free implant provides deep, localized relief in the feet and legs without full-body stimulation.

Axon mPNS

Non-Invasive Magnetic Pain Relief

Axon mPNS offers a 100% non-invasive, drug-free approach to diabetic nerve pain with no surgery or implants. Delivered via quick, painless magnetic pulses through the skin during brief office visits, it resets hyperactive nerve pathways to relieve chronic burning and tingling.

Spinal Cord Stimulation

Implantable Spinal Stimulation

Spinal Cord Stimulation (SCS) is a proven, non-opioid implantable therapy. Delivering mild electrical currents near the spine via a minimally invasive procedure, it disrupts pain signals and replaces raw burning or shooting pain with a gentle tingling. 

Qutenza

Targeted Topical Patch Relief

Qutenza is an FDA-approved 8% capsaicin topical patch applied during a brief office visit. It works directly at the skin level to desensitize hyperactive pain receptors in the feet, providing up to three months of localized relief without the systemic side effects of oral drugs.

Request An Appointment

Please feel free to contact our friendly reception staff with any general or medical inquiry

DOUBLE BOARD-CERTIFIED

Dr. David J. Arcella

Dr. David J. Arcella is a Harvard trained Interventional Pain Management Specialist. He has contributed to research in opioid alternative medications and medication-free pain management options, as well as surgical anesthesia techniques to minimize the incidence of chronic pain. Dr. Arcella believes in creating a collaborative care plan with his patients and customizing treatments to each patient’s individual goals.

Testimonials

ACCEPTED

Insurances

  • Aetna
  • All BCBS plans

  • Cigna

  • Humana

  • Mail Handlers

  • Medicare

  • MedicareMedicare HMO’s

  • Medicost
  • Out of Network
    (In network with Molina Healthcare or Wellcare)
  • Planned Administrators

  • Thomas Cooper

  • Tricare

  • United Healthcare

  • Work Comp

Insurances We Accept DeNovo Pain Management
ACCEPTED

Insurances

  • Aetna
  • All BCBS plans

  • Cigna

  • Humana

  • Mail Handlers

  • Medicare

  • MedicareMedicare HMO’s

  • Medicost
  • Out of Network
    (In network with Molina Healthcare or Wellcare)
  • Planned Administrators

  • Thomas Cooper

  • Tricare

  • United Healthcare

  • Work Comp

References: 

  1. CDC 2020 National Diabetes Statistics Report.
  2. Hicks CW, Selvin E. Curr Diab Rep. 2019;19(10):86
  3. CDC National Diabetes Statistics Report 2020; Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18(6):350-354; Trinity Partners Market Research 2017
  4. Petersen, E, et. al. Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy A Randomized Clinical Trial. JAMA Neurology, April 2021.

References: 

  1. CDC 2020 National Diabetes Statistics Report.
  2. Hicks CW, Selvin E. Curr Diab Rep. 2019;19(10):86
  3. CDC National Diabetes Statistics Report 2020; Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18(6):350-354; Trinity Partners Market Research 2017
  4. Petersen, E, et. al. Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy A Randomized Clinical Trial. JAMA Neurology, April 2021.